Kelly Roman is the Co-Founder and CEO of Fisher Wallace Laboratories, an FDA-regulated manufacturer of a cutting edge wearable medtech device designed to treat insomnia, anxiety, and depression.
Fisher Wallace has over 70,000 patients and 10,000 subscribers using their devices and has continued to run three sizable clinical trials during the pandemic, investigating how neurostimulation is a strong contender as a treatment for anxiety and depression compared to drug use.